Protalix Biotherapeutics Trading Update
Protalix Biotherapeutics (PLX) closed the trading session on Friday, 23 March 2026, at a price of USD 2.57, reflecting a decline of 2.65 % over the 24‑hour period ending at 02:45 AM Central Europe time. The current trading price is USD 2.57 per share on major exchanges.
Market Metrics
- Shares outstanding: 80.6 million
- Market capitalization: USD 211.1 million
- Volume traded (last 24 h): USD 1.4 million
- 24‑hour price change: –9.51 % from the previous month‑end close
- 200‑day simple moving average: USD 2.39
- 52‑week high: USD 3.19 (recorded 23 Feb 2026)
- 52‑week low: USD 1.65 (recorded 3 Dec 2025)
Comparative Performance (last 24 h)
| Stock | Ticker | 24‑hour change | Current price | Market cap |
|---|---|---|---|---|
| Ceragon Networks | CRNT | +0.5 % | USD 1.94 | USD 182.6 million |
| Sol‑gel | SLGL | –0.14 % | USD 67.13 | USD 215.5 million |
| Mizrahi Tefahot Bank | MZTF.TA | –0.25 % | ILA 23,410 | ILA 19.9 billion (PE 11.1) |
| Valens Semiconductor | VLN | +1.26 % | USD 1.47 | USD 172.2 million |
| Phoenix | PHOE.TA | +1.73 % | ILA 18,540 | ILA 15.4 billion (PE 14.45) |
Company Overview
Protalix Biotherapeutics Inc. is a biotechnology firm that has developed plant cell culture technology and bioreactor systems. The company focuses on creating innovative therapeutic solutions and operates within the health‑care services sector. Its products and technology are detailed on the corporate website, www.protalix.com . Protalix Biotherapeutics trades on the NYSE MKT exchange. The company’s initial public offering was executed on 15 May 1998.
